Narrow search
Showing 1 - 10 of 654,351
Cover Image
Impact of regulatory control on the pharmaceutical industry
Wu, Wenchen - 1988
Persistent link: https://www.econbiz.de/10000931057
Cover Image
The effects of price regulation on productivity in pharmaceuticals
Danzon, Patricia Munch; Percy, Allison - In: International and interarea comparisons of income, …, (pp. 371-416). 1999
Persistent link: https://www.econbiz.de/10001471317
Cover Image
Innovation im Arzneimittelmarkt
Klauber, Jürgen (ed.); Bausch, Jürgen (contributor);  … - 2000
Persistent link: https://www.econbiz.de/10001486392
Cover Image
Cross-national price differences for pharmaceuticals : how large, and why?
Danzon, Patricia Munch; Chao, Li-wei - In: Journal of health economics 19 (2000) 2, pp. 159-195
Persistent link: https://www.econbiz.de/10001511446
Cover Image
Rethinking the link between labour market flexibility and corporate competitiveness : a critique of the institutionalist literature
Herrmann, Andrea - In: Socio-economic review 6 (2008) 4, pp. 637-669
Persistent link: https://www.econbiz.de/10003774734
Cover Image
European medicines pricing and reimbursement : now and the future
Garau, Martina (contributor);  … - 2006
Persistent link: https://www.econbiz.de/10003377526
Cover Image
On the discrepancies between macro and micro level identification of competitive strategies
Herrmann, Andrea (contributor) - 2007
Persistent link: https://www.econbiz.de/10003647080
Cover Image
One political economy, one competitive strategy? : Comparing pharmaceutical firms in Germany, Italy, and the UK
Herrmann, Andrea - 2008
"One Political Economy, One Competitive Strategy? begins with an assessment of how many pharmaceutical firms in Germany …, Italy, and the UK pursue strategies facilitated by national institutions governing the financial markets, antitrust …
Persistent link: https://www.econbiz.de/10003720773
Cover Image
Choosing and successfully sustaining competitive strategies in the European pharmaceutical industry
Herrmann, Andrea - 2008
successful and therefore not sustainable in the long run. My analyses of pharmaceutical firms in Germany, Italy and the United … nicht von Bestand sind. Die im Rahmen dieses Projekts durchgeführten Untersuchungen von Pharmazieunternehmen in Deutschland …, Italien und Großbritannien lassen Zweifel an diesen Argumenten zu Wahl und Erfolg von Wettbewerbsstrategien entstehen. Da …
Persistent link: https://www.econbiz.de/10003819894
Cover Image
On the discrepancies between macro and micro level identification of competitive strategies
Herrmann, Andrea - 2008
As economic internationalization advances, the question of how firms cope with increasing pressure for competitiveness gains momentum. While scholars agree that firms need a competitive advantage, they debate whether firms exploit the comparative advantage of their economy and converge on that...
Persistent link: https://www.econbiz.de/10003729642